Natural Product (NP) Details
General Information of the NP (ID: NP2740) | |||||
---|---|---|---|---|---|
Name |
Borneol
|
||||
Synonyms |
isoborneol; (+)-borneol
Click to Show/Hide
|
||||
Species Origin | Chrysanthemum x morifolium ... | Click to Show/Hide | |||
Chrysanthemum x morifolium | |||||
Valeriana jatamansi | |||||
Liquidambar formosana | |||||
Alpinia zerumbet | |||||
Baeckea frutescens | |||||
Annona squamosa | |||||
Abutilon indicum | |||||
Prunus triloba | |||||
Disease | Asthma [ICD-11: CA23] | Investigative | [1] | ||
Structure |
Click to Download Mol2D MOL |
||||
Click to Show/Hide the Molecular Information and External Link(s) of This Natural Product | |||||
Formula |
C10H18O
|
||||
PubChem CID | |||||
Canonical SMILES |
CC1(C2CCC1(C(C2)O)C)C
|
||||
InChI |
1S/C10H18O/c1-9(2)7-4-5-10(9,3)8(11)6-7/h7-8,11H,4-6H2,1-3H3
|
||||
InChIKey |
DTGKSKDOIYIVQL-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 507-70-0
|
||||
Herb ID | |||||
ETMC ID | |||||
SymMap ID | |||||
TTD Drug ID |
Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally | ||||||
---|---|---|---|---|---|---|
α. A List of Drug(s) Whose Efficacy can be Enhanced by This NP | ||||||
Temozolomide | Brain cancer | Click to Show/Hide the Molecular Data of This Drug | ||||
Augmenting Drug Sensitivity | Click to Show/Hide | |||||
Representative Experiment Reporting the Effect of This Combination | [2] | |||||
Detail(s) | Combination Info click to show the detail info of this combination | |||||
Molecule(s)
Regulation |
Up-regulation | Phosphorylation | ATM | Molecule Info |
Pathway MAP
|
|
Up-regulation | Activity | CASP3 | Molecule Info |
Pathway MAP
|
||
Up-regulation | Activity | CASP7 | Molecule Info |
Pathway MAP
|
||
Up-regulation | Activity | CASP9 | Molecule Info |
Pathway MAP
|
||
Up-regulation | Phosphorylation | FRP1 | Molecule Info |
Pathway MAP
|
||
Up-regulation | Phosphorylation | TP53 | Molecule Info |
Pathway MAP
|
||
In-vitro Model | U-251MG | CVCL_0021 | Astrocytoma | Homo sapiens | ||
In-vivo Model | U251 cell suspension (1*109 cells) was inoculated in the armpit of 6-week-old Balb/c nude mice. | |||||
Experimental
Result(s) |
Natural borneol enhances temozolomide-induced anticancer efficiency against human glioma by triggering mitochondrial dysfunction and reactive oxide species-mediated oxidative damage. | |||||
Doxorubicin | Solid tumour/cancer | Click to Show/Hide the Molecular Data of This Drug | ||||
Augmenting Drug Sensitivity | Click to Show/Hide | |||||
Representative Experiment Reporting the Effect of This Combination | [3] | |||||
Detail(s) | Combination Info click to show the detail info of this combination | |||||
Molecule(s)
Regulation |
Down-regulation | Phosphorylation | AKT1 | Molecule Info |
Pathway MAP
|
|
Down-regulation | Expression | CCNB1 | Molecule Info |
Pathway MAP
|
||
Up-regulation | Phosphorylation | ERK1 | Molecule Info |
Pathway MAP
|
||
Up-regulation | Phosphorylation | JNK1 | Molecule Info |
Pathway MAP
|
||
Down-regulation | Expression | POLD1 | Molecule Info |
Pathway MAP
|
||
Biological
Regulation |
Up-regulation | Cell cycle arrest in G2/M phase | ||||
Up-regulation | ROS generation | |||||
In-vitro Model | U-251MG | CVCL_0021 | Astrocytoma | Homo sapiens | ||
U-87MG ATCC | CVCL_0022 | Glioblastoma | Homo sapiens | |||
In-vivo Model | U251 cells (5*107) in 100 uL PBS were injected subcutaneously into the right oxter of male nude mice. | |||||
Experimental
Result(s) |
Borneol could enhance anticancer efficiency of doxorubicin against human glioma through triggering ROS-mediated signal. |
Target and Pathway | ||||
---|---|---|---|---|
Target(s) | Transient receptor cation channel V3 (TRPV3) | Molecule Info | [4] | |
KEGG Pathway | Inflammatory mediator regulation of TRP channels | Click to Show/Hide | ||
Reactome | TRP channels | Click to Show/Hide |